New York S 3220: Relates to establishing an office of antibiotic resistance control and to establishing the antibiotics education fund

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S03220 Summary:

BILL NOS03220 

&nbsp

SAME ASSAME AS A01667

&nbsp

SPONSORKAVANAGH

&nbsp

COSPNSRADDABBO, CLEARE, GOUNARDES, HOYLMAN-SIGAL, JACKSON, MYRIE

&nbsp

MLTSPNSR

&nbsp

Add Art 2 Title 9 §§269-a - 269-n, Pub Health L; add §97-aaaa, St Fin L; amd §218-b, Lab L

&nbsp

Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.

Go to top S03220 Actions:

BILL NOS03220 

&nbsp

01/24/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

Go to topS03220 Committee&nbspVotes:

Go to topS03220 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS03220 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 3220

 2025-2026 Regular Sessions

 IN SENATE

 January 24, 2025
 ___________

 Introduced by Sens. KAVANAGH, ADDABBO, CLEARE, GOUNARDES, HOYLMAN-SIGAL,
 JACKSON, MYRIE -- read twice and ordered printed, and when printed to
 be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to establishing an
 office of antibiotic-resistance control; to amend the state finance
 law, in relation to establishing the antibiotics education fund; and
 to amend the labor law, in relation to including methicillin-resistant
 staphylococcus aureus (MRSA) and other antibiotic-resistant infections
 in the definition of airborne infectious disease

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Legislative findings. Antibiotics are rightfully considered
 2 one of the medical miracles of the last century because of their power-
 3 ful ability to fight illness and disease caused by bacteria. But the
 4 effectiveness of medically important antibiotics is now at great risk
 5 due to their misuse and overuse in medicine and agriculture. Many
 6 strains of bacteria have evolved resistance to antibiotics, meaning
 7 instead of being killed by the drugs, they survive, multiply, and
 8 spread. In fact, the more antibiotics are used, the faster antibiotic-
 9 resistant bacteria (aka "superbugs") emerge, increasing the risk of
 10 contracting an antibiotic-resistant infection. If effective policy meas-
 11 ures are not soon adopted, some experts predict that by 2050, antibiot-
 12 ic-resistant infections will be responsible for more annual deaths than
 13 cancer.
 14 In recognition of the serious public health threat posed by antibiot-
 15 ic-resistant infections, the United Nations General Assembly in 2016
 16 committed to taking action. The World Health Organization (WHO) consid-
 17 ers it to be one of the biggest threats to global health, food security,
 18 and international development today. The United States Centers for
 19 Disease Control and Prevention (CDC) has stated that fighting this
 20 threat is a public health priority and estimates that each year, antibi-

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03935-01-5

 S. 3220 2

 1 otic-resistant bacteria are responsible for at least 2.8 million
 2 infections in the United States and at least 35,000 deaths. A study
 3 commissioned by the United Kingdom government predicts that if action is
 4 not taken now to combat antibiotic resistance, by 2050 the annual death
 5 toll will have risen to 10 million globally. Most major medical and
 6 health groups in the United States, including the American Medical Asso-
 7 ciation, American Academy of Pediatrics, and Infectious Diseases Society
 8 of America, have recognized the urgency of the antibiotic-resistance
 9 crisis. New York State, in its Prevention Agenda 2019-2024, established
 10 Antibiotic Resistance and Healthcare-Associated Infections as one of
 11 five major focus areas.
 12 Antibiotic-resistant bacteria are bacteria that are immune to the
 13 effect of antibiotics. These so-called "superbugs" can infect humans and
 14 animals, and the infections they cause are harder and sometimes impossi-
 15 ble to treat. Antibiotic resistance is a naturally occurring phenomenon,
 16 but the speed at which superbugs